Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Meihua International Medical Technologies Co Ltd (MHUA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: MHUA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -58.57% | Avg. Invested days 21 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.36M USD | Price to earnings Ratio 1.13 | 1Y Target Price - |
Price to earnings Ratio 1.13 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.85 | 52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 |
52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.4 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.19% | Operating Margin (TTM) 16.33% |
Management Effectiveness
Return on Assets (TTM) 5% | Return on Equity (TTM) 7.09% |
Valuation
Trailing PE 1.13 | Forward PE - | Enterprise Value 6349300 | Price to Sales(TTM) 0.15 |
Enterprise Value 6349300 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.07 | Enterprise Value to EBITDA 0.4 | Shares Outstanding 31904500 | Shares Floating 15734833 |
Shares Outstanding 31904500 | Shares Floating 15734833 | ||
Percent Insiders 49.95 | Percent Institutions 1.06 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Meihua International Medical Technologies Co Ltd
Company Overview
History and Background
Meihua International Medical Technologies Co Ltd is a medical device supplier. More detailed historical information is difficult to source publicly as of late 2024.
Core Business Areas
- Disposable Medical Device: Manufacturing and sales of a variety of disposable medical devices.
Leadership and Structure
Information about the leadership team and detailed organizational structure is not easily available in public sources. Generally structured as a manufacturing company with sales and distribution departments.
Top Products and Market Share
Key Offerings
- Surgical and Examination Gloves: Manufacture and sales of surgical and exam gloves. Market share information is not readily available for this specific brand or product. Competition includes companies like Cardinal Health, Medline Industries, and Ansell.
- Other Medical Disposables: This include medical protective products, medical dressings, medical equipments, etc. Market share information is not readily available for this specific product or brand. Competition includes companies like Cardinal Health, Medline Industries.
Market Dynamics
Industry Overview
The global medical device industry is experiencing growth driven by aging populations, increasing healthcare expenditures, and technological advancements. Demand for disposable medical devices is influenced by infection control protocols and surgical procedure volumes.
Positioning
Meihua International is positioned as a global medical device supplier that specializes in the production and distribution of disposable medical devices with competitive pricing strategies.
Total Addressable Market (TAM)
The global disposable medical supplies market is estimated to be in the hundreds of billions of dollars, and Meihua is positioned to address a portion of this TAM, focusing on price-sensitive segments.
Upturn SWOT Analysis
Strengths
- Established manufacturing capabilities
- Potentially Cost-competitive pricing
- Global distribution network
Weaknesses
- Limited brand recognition
- Dependence on single-product or single area segments
- Potentially limited R&D capabilities
Opportunities
- Expanding into new geographic markets
- Developing innovative medical device products
- Capitalizing on growing demand for disposable medical supplies
Threats
- Intense competition from established players
- Regulatory changes in the medical device industry
- Fluctuations in raw material prices
Competitors and Market Share
Key Competitors
- Cardinal Health (CAH)
- Medline Industries (Private)
- Ansell (ANSLY)
Competitive Landscape
Meihua International faces a competitive market with established players. Its competitive advantage may depend on pricing, quality, and distribution network. The market share for MUHA is zero because the company is too new to the exchange.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data depends on past revenue figures.
Future Projections: Future projections depend on analyst estimates and company guidance.
Recent Initiatives: Recent initiatives may include expanding production capacity or entering new markets.
Summary
Meihua International Medical Technologies Co Ltd is a small new supplier in the competitive disposable medical device market. Its success hinges on factors like price competitiveness, product quality, and effective distribution. Monitoring market trends and regulatory changes is vital for sustainable growth. The company's future trajectory will depend on strategic expansion and innovation within the industry. More detailed financial information needs to be researched due to the lack of information to the public.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company press releases
- Industry reports
- Market analysis reports
- Financial data providers
- Sec.gov
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share percentages are estimates and may not reflect precise figures. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Meihua International Medical Technologies Co Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2022-02-16 | CEO & Director Mr. Wang Xin | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 619 | Website https://www.meihuamed.com |
Full time employees 619 | Website https://www.meihuamed.com | ||
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; and medical x-ray films and multi-functional self-extracting X-ray film machines. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.